Table 4.

Proteus Syndrome: Treatment of Manifestations

Manifestation/ConcernTreatmentConsiderations/Other
Skeletal overgrowth
  • Mgmt per orthopedist
  • Epiphysiostasis & epiphysiodesis for overgrowth of tubular bones 1
One intervention that the authors have found to be detrimental to persons w/PS is distraction osteotomy (Ilizarov procedure) performed on the normal (shorter) limbs. 2
  • Mgmt by rehab medicine, incl PT & OT
  • Custom-designed footwear or orthotics due to leg-length inequality
The skeletal overgrowth of PS can result in significant biomechanical & functional compromise.
Scoliosis
  • Referral to orthopedist if scoliosis is identified on clinical &/or radiographic exam
  • Frequent monitoring due to risk of rapid progression 2
  • Surgery is often indicated, as progressive nature of scoliosis can lead to fatal restrictive lung disease.
Scoliosis surgery is high risk in persons w/PS; DVT & PE have led to death even w/prophylactic anticoagulation. 3
CCTN
  • Mgmt by dermatologist
  • Monitor for pressure ulcerations & malodor (due to difficulty w/cleanliness of deepening sulci in late adolescence)
  • Pedorthic referral as needed for issues w/shoe fit
Surgical removal of CCTN has been successfully accomplished in ≥2 persons.
Overgrowth of lipomatous tissue / lipoatrophy Open surgical approaches are preferred to liposuction because highly vascularized lipomatous overgrowth in some persons can result in difficult-to-control hemorrhaging &/or chronically weeping lymphatics. 1Mgmt is challenging because areas of adipose overgrowth are not encapsulated & discrete (in contrast to lipomas), can be difficult to resect, & commonly regrow after surgical debulking.
DVT & PE Emergent eval for signs/symptoms of DVT (e.g., palpable subcutaneous rope-like mass, swelling, erythema, pain, distal venous congestion) or PE (e.g., shortness of breath, chest pain, cough, hemoptysis).
  • Eval for DVTs: in absence of cardiopulmonary compromise, consider D-dimer assay &/or US eval.
  • Eval of PE: high-resolution chest CT (spiral CT) w/contrast. Ventilation-perfusion nuclear medicine scanning may be appropriate in some persons.
  • Treatment of DVT & PE should follow recommended anticoagulation guidelines for these disorders.
  • Persons w/PE can be asymptomatic; therefore, a person w/DVT should be evaluated for PE regardless of symptoms.
  • Note: Hematologic consultation for consideration of anticoagulant prophylaxis for persons undergoing surgery or other procedures that may predispose to DVT/PE is recommended.
Tumors Treatment for tumors per surgeon &/or oncologist 1
Bullous pulmonary disease
  • Pulmonary eval for persons w/bullous pulmonary disease
  • Resection of large bullous lesions may be indicated in some persons. 1
Bullous disease in context of scoliosis can pose significant & complex challenges for appropriate mgmt.
Developmental delay Developmental & educational support incl special education as needed for those w/developmental delays.
Psychosocial issues Psychosocial counseling as neededAlthough PS is exceedingly rare, a robust support group infrastructure exists, & many families find this very helpful (see Resources).

CCTN = cerebriform connective tissue nevi; DVT = deep vein thrombosis; OT = occupational therapy; PE = pulmonary embolism; PS = Proteus syndrome; PT = physical therapy; US = ultrasound

1.

Hematologic consultation for consideration of anticoagulant prophylaxis for individuals undergoing surgery or other procedures that may predispose to DVT/PE is recommended.

2.
3.

Authors, personal observation

From: Proteus Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.